A multi-centre study investigating the pharmacokinetics of treosulfan in children undergoing stem cell transplantation.

Not Applicable

Recruiting

• Conditions: immunodeficiency; CD40 ligand deficiency; mucopolysaccharidosis; infantile malignant osteoporosis; Human Genetics and Inherited Disorders - Other human genetics and inherited disorders; Cancer - Children's - Other

• Registration Number: ACTRN12615000038594
• Lead Sponsor: The Children's Hospital at Westmead

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-01-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Children and adolescents with any diagnosis who are scheduled to receive tresosulfan-based conditioning prior to blood or marrow transplantation.
2. Parental informed consent.

Exclusion Criteria

Unable to obtain parental informed consent.

Study & Design

• Study Type: Observational
• Study Design: Not specified